Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)

Fig. 3

Beanplot summarizing the changes in TILs before and after NET in responders and non-responders. R_pre-NET pre-neoadjuvant endocrine therapy samples in responders, R_post-NET post-neoadjuvant endocrine therapy samples in responders, NR_pre-NET pre-neoadjuvant endocrine therapy samples in non-responders, NR_post-NET post-neoadjuvant endocrine therapy samples in non-responders. NS not significant. **p value < 0.01

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us